Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM245 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RIOK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORD23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C6orf89 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
E2F1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXorf40B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC92 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHMP1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PFKL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FEM1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WNT5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2Z - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAA60 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OPTN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MOSPD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on